Latest Partnerships News

Parkway Corporate Limited has marked its transition to profitability in FY25, unveiling a transformative Queensland Brine Management Complex project set to redefine waste brine processing in Australia’s coal seam gas sector.

Riversgold Limited has reported promising assay results from its latest drilling campaign at the Northern Zone of the Kalgoorlie Gold Project, revealing significant gold mineralisation and expanding the known deposit footprint.

Elixir Energy has raised approximately AUD 16.6 million through a two-tranche placement led by Omega Oil & Gas, aiming to fast-track its Taroom Trough gas projects and advance toward commercial production.

Lodestar Minerals has kicked off its first-ever exploration program at the Virgin Mountain Rare Earth Project in Arizona, targeting historically promising heavy and light rare earth elements amid shifting global supply dynamics.

Genesis Energy’s 2025 Investor Day confirms its strategy and earnings growth remain firmly on track, anchored by a substantial renewable pipeline and robust capital management.

Aura Energy’s 2025 AGM highlights strong uranium market fundamentals and strategic progress on its Tiris Project, despite some engineering delays. The company also strengthens its board and deepens ties in Mauritania as it prepares for production.

West African Resources is advancing negotiations with the Burkina Faso Government over equity interests in its Kiaka gold project, proposing alternatives to direct government ownership to boost national benefits without diluting shareholder value.

Osteopore Limited has drawn an additional A$250,000 under the first tranche of its redeemable convertible notes, continuing its steady capital raise to support growth and innovation.

Nex Metals Explorations reported no exploration spending in Q1 FY26 but made significant strides by finalising a profit-sharing deal for its Kookynie project and entering Egypt’s Eastern Desert mining scene.

Zelira Therapeutics has received a $1.07 million cash refund under Australia’s R&D Tax Incentive Scheme, reinforcing its funding for ongoing clinical trials and product development. The company has also repaid a prior loan advanced against this claim, positioning it for continued growth in cannabinoid-based medicines.

Macquarie Technology Group unveiled ambitious plans to expand its AI-optimised data centre footprint, supported by a $450 million debt facility and strong growth across its cloud, government cybersecurity, and telecom divisions.

Comms Group reported robust FY25 results driven by domestic expansion, including the strategic acquisition of TasmaNet, and strong international growth in its Global and Wholesale division.